From the 1Department of Psychiatry, McGill University, Montreal, Quebec, Canada

2Division of Psychiatry, Imperial College, London, United Kingdom

Departments of 3Pharmaceutical and Pharmacological Sciences

4Biomedical Sciences, University of Padova, Padova, Italy

5McGill University Health Center, Montreal, Quebec, Canada.

Received May 19, 2023; accepted after revision August 4, 2023.

Address correspondence to: Gabriella Gobbi, MD, PhD, Neurobiological Psychiatry Unit, Room 220, 1033 Pine Ave West, McGill University, Montreal, Quebec, Canada H3A 1A1 (e-mail: [email protected]).

N.N. is now with the Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN.

C.M. and J.D.K. have contributed equally to this study.

Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal’s Web site (www.psychopharmacology.com).